[Clinical pharmacology of hepatoprotectors].
Data from published literature are summarized together with findings secured in the author's investigations on clinical pharmacology of hepatoprotectors. Classification of hepatoprotectors is submitted, their effects on the functional condition and metabolism in hepatocytes are discussed. Details are given of clinical and pharmacological properties of hepabene, legalon, essentiale, sirepara, wobenzime, phebichol, antral, thiotriazone.
I S
IS
Chekman
D000818:Animals; D005419:Flavonoids / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008107:Liver Diseases / Q000188:drug therapy*; D008111:Liver Function Tests; D010713:Phosphatidylcholines / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D028321:Plant Preparations / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D020011:Protective Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use
D005419:Flavonoids; D010713:Phosphatidylcholines; D028321:Plant Preparations; D020011:Protective Agents